Kenichi Yamamura
Research Subjects
Kenichi Yamamura has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Zhenghua Li
Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan
4 shared publications - Aki Sugano
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
1 shared publication - Hideki Kanazashi
Transgenic, Inc., Kobe, Japan
1 shared publication Mika Ohta
Division of Medical Informatics and Bioinformatics, Kobe University Hospital, Kobe, Japan
1 shared publicationNaoko Matsushita
Transgenic, Inc., Kobe, Japan
1 shared publicationRie Fujikawa
Transgenic, Inc., Kobe, Japan
1 shared publication
Latest Publications
- Open Access
- 26 October 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (04) , 01-06
Quantitative Classification of Parkinsonian Gait Disturbances Using Telemetry: Differentiating Akinetic Freezing and Inefficient Tremulous Gait
Background: We previously demonstrated that freezing of gait (FOG) in Parkinson’s disease (PD) can be objectively assessed using consumer smartwatch telemetry and that FOG episodes introduce significant spatial GPS distance distortion. However, parkinsonian gait impairment comprises distinct motor subtypes, notably complete motor arrest (akinetic freezing) and irregular shuffling gait. Objective: To determine whether these distinct manifestations can be quantitatively evaluated and differentiated using telemetry metrics derived from structured field walking tests. Methods: We conducted outdoor walking test trials on a standardized park pathway using Apple Watch Ultra 2 (WorkOutDoors and HealthFit). Quantitative telemetry metrics included the Measurement Error Rate (MER: [(Recorded Distance - Map Distance) / Map Distance] × 100%) and the FOG Ratio (Freezing Time / Total Time). Results: FOG Ratio strongly correlated with walking speed (r = -0.869, p < 0.001) and cadence (r = -0.848, p < 0.001). Crucially, MER showed no correlation with FOG Ratio (r = 0.135, p = 0.659) or walking speed (r = -0.096, p = 0.755). Conclusion: FOG Ratio and MER represent orthogonal dimensions of gait impairment. This decoupling establishes a quantitative classification differentiating Akinetic Freezing (high FOG Ratio, low MER) from Inefficient Tremulous Gait (high MER), providing a refined framework for digital gait telemetry.
- 26 October 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (04) , 01-06
Open AccessQuantitative Classification of Parkinsonian Gait Disturbances Using Telemetry: Differentiating Akinetic Freezing and Inefficient Tremulous Gait
Background: We previously demonstrated that freezing of gait (FOG) in Parkinson’s disease (PD) can be objectively assessed using consumer smartwatch telemetry and that FOG episodes introduce significant spatial GPS distance distortion. However, parkinsonian gait impairment comprises distinct motor subtypes, notably complete motor arrest (akinetic freezing) and irregular shuffling gait. Objective: To determine whether these distinct manifestations can be quantitatively evaluated and differentiated using telemetry metrics derived from structured field walking tests. Methods: We conducted outdoor walking test trials on a standardized park pathway using Apple Watch Ultra 2 (WorkOutDoors and HealthFit). Quantitative telemetry metrics included the Measurement Error Rate (MER: [(Recorded Distance - Map Distance) / Map Distance] × 100%) and the FOG Ratio (Freezing Time / Total Time). Results: FOG Ratio strongly correlated with walking speed (r = -0.869, p < 0.001) and cadence (r = -0.848, p < 0.001). Crucially, MER showed no correlation with FOG Ratio (r = 0.135, p = 0.659) or walking speed (r = -0.096, p = 0.755). Conclusion: FOG Ratio and MER represent orthogonal dimensions of gait impairment. This decoupling establishes a quantitative classification differentiating Akinetic Freezing (high FOG Ratio, low MER) from Inefficient Tremulous Gait (high MER), providing a refined framework for digital gait telemetry.
- Open Access
- 10 September 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (03) , 01-09
Quantitative Evaluation of Freezing of Gait in Parkinson’s Disease Using Smartwatch Telemetry
Background: Freezing of Gait (FOG) and daily motor fluctuations severely impair independence in Parkinson’s disease (PD). Continuous monitoring via consumer smartwatches offers a non-invasive way to measure real-world Digital Mobility Outcomes (DMOs). However, FOG-induced standstill and environmental variations cause measurement biases that are poorly characterized. Objective: To quantitatively evaluate Freezing of Gait (FOG) episodes in Parkinson’s disease using smartwatch telemetry, establish a simple and clinically intuitive Range Ratio metric (Mean ± Range Ratio %) to capture true day-to-day symptom variability without relying on standard deviation, assess FOG-induced GPS trajectory distance distortion, and investigate the potential moderating effects of ambient biometeorological factors (temperature and relative humidity) on gait motor performance. Methods: Field gait trials were conducted along an outdoor circuit (Fukuoka Park) ranging from 240 m to 800 m comparing Control sessions (n=4) and Test sessions exhibiting FOG (n=15). High-frequency time-series sensor data were recorded using the WorkOutDoors application on an Apple Watch Ultra 2 and analyzed via HealthFit and custom Excel processing pipelines. Day-to-day symptom variability across the 15 Test sessions was expressed using the Range Ratio (Mean±Range Ratio %), defined as [(Max−Min)/Mean]×100. Results: High-precision telemetry successfully extracted continuous spatiotemporal metrics. Test sessions exhibited significantly higher FOG Ratio (0.320 vs. 0.037, p = 2.26 × 10^-7) and massive GPS distance inflation (32.10% vs. 1.25%, p = 7.94 × 10^-8) compared to Controls. FOG Ratio showed strong inverse correlations with walking speed (r = -0.742) and step length (r = -0.685), confirming that spatial gait breakdown closely mirrors freezing severity. Across 15 test sessions, day-to-day symptom ranges expressed as Mean ± Range Ratio % were: FOG Ratio 0.32 ± 145.6%, Walking Speed 3.12 ± 55.8% km/h, Cadence 125.6 ± 39.9% spm, and Step Length 45.8 ± 27.1% cm. Ambient temperature showed no significant association with FOG Ratio (r = 0.188, p = 0.503) or GPS error (r = 0.284, p = 0.305). Conversely, relative humidity demonstrated a statistically significant inverse correlation with FOG Ratio (r = -0.594, p = 0.020) and GPS error ratio (r = -0.656, p = 0.008). Conclusion: FOG Ratio derived from smartwatch telemetry is an exceptionally sensitive biomarker for capturing realworld day-to-day motor symptom swings (145.6% fluctuation). GPS distance inflation during FOG motor arrest (~32%) mandates the integration of inertial zero-velocity filters in DMO algorithms. Environmental humidity modulates freezing severity, presenting new biometeorological insights for PD motor management.
- 10 September 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (03) , 01-09
Open AccessQuantitative Evaluation of Freezing of Gait in Parkinson’s Disease Using Smartwatch Telemetry
Background: Freezing of Gait (FOG) and daily motor fluctuations severely impair independence in Parkinson’s disease (PD). Continuous monitoring via consumer smartwatches offers a non-invasive way to measure real-world Digital Mobility Outcomes (DMOs). However, FOG-induced standstill and environmental variations cause measurement biases that are poorly characterized. Objective: To quantitatively evaluate Freezing of Gait (FOG) episodes in Parkinson’s disease using smartwatch telemetry, establish a simple and clinically intuitive Range Ratio metric (Mean ± Range Ratio %) to capture true day-to-day symptom variability without relying on standard deviation, assess FOG-induced GPS trajectory distance distortion, and investigate the potential moderating effects of ambient biometeorological factors (temperature and relative humidity) on gait motor performance. Methods: Field gait trials were conducted along an outdoor circuit (Fukuoka Park) ranging from 240 m to 800 m comparing Control sessions (n=4) and Test sessions exhibiting FOG (n=15). High-frequency time-series sensor data were recorded using the WorkOutDoors application on an Apple Watch Ultra 2 and analyzed via HealthFit and custom Excel processing pipelines. Day-to-day symptom variability across the 15 Test sessions was expressed using the Range Ratio (Mean±Range Ratio %), defined as [(Max−Min)/Mean]×100. Results: High-precision telemetry successfully extracted continuous spatiotemporal metrics. Test sessions exhibited significantly higher FOG Ratio (0.320 vs. 0.037, p = 2.26 × 10^-7) and massive GPS distance inflation (32.10% vs. 1.25%, p = 7.94 × 10^-8) compared to Controls. FOG Ratio showed strong inverse correlations with walking speed (r = -0.742) and step length (r = -0.685), confirming that spatial gait breakdown closely mirrors freezing severity. Across 15 test sessions, day-to-day symptom ranges expressed as Mean ± Range Ratio % were: FOG Ratio 0.32 ± 145.6%, Walking Speed 3.12 ± 55.8% km/h, Cadence 125.6 ± 39.9% spm, and Step Length 45.8 ± 27.1% cm. Ambient temperature showed no significant association with FOG Ratio (r = 0.188, p = 0.503) or GPS error (r = 0.284, p = 0.305). Conversely, relative humidity demonstrated a statistically significant inverse correlation with FOG Ratio (r = -0.594, p = 0.020) and GPS error ratio (r = -0.656, p = 0.008). Conclusion: FOG Ratio derived from smartwatch telemetry is an exceptionally sensitive biomarker for capturing realworld day-to-day motor symptom swings (145.6% fluctuation). GPS distance inflation during FOG motor arrest (~32%) mandates the integration of inertial zero-velocity filters in DMO algorithms. Environmental humidity modulates freezing severity, presenting new biometeorological insights for PD motor management.
- Open Access
- 19 August 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (03) , 01-17
TTR Exon-Humanized Mice as a Model for Genotype-Dependent Transthyretin Deposition: Supportive Evidence for RBP4 as a Natural Stabilizer
Transthyretin amyloidosis is caused by destabilization, dissociation, and tissue deposition of transthyretin (TTR). Although several transgenic and knock-in mouse models have been generated, many models are limited by nonphysiological copy number, low expression, or the formation of hybrid tetramers between mouse and human TTR. We previously generated TTR exon-humanized mice in which mouse Ttr exons were replaced with corresponding human TTR exons while preserving the mouse genomic structure. In the present study, we introduced the Val30Met mutation into the TTR exon-humanized allele and generated three genotypes: TtrhTTRV30e/hTTRV30e, TtrhTTRM30e/hTTRM30e, and TtrhTTRV30e/hTTRM30e mice. We examined non-fibrillar human TTR deposition by immunohistochemistry in ileum, kidney, and sciatic nerve at 26 and 52 weeks of age, using a semi-quantitative scoring system. Genotype-dependent TTR deposition was observed in multiple tissues. TTR deposition was prominent in V30/V30 and V30/M30 mice, whereas M30/M30 mice consistently showed lower deposition scores. Notably, TTR-positive deposits were detected in the sciatic nerve at 52 weeks of age. Direct fast scarlet staining did not detect amyloid fibrils, indicating that the observed deposits represented non-fibrillar or pre-amyloid TTR deposition. Serum human TTR levels showed modest genotype-dependent differences, whereas serum mouse RBP4 levels differed markedly among genotypes. Supportive computer simulation analysis suggested that the predicted binding stability between mouse RBP4 and TTR was highest for mouse TTR, intermediate for human TTR Met30, and lowest for human TTR Val30. These findings indicate that TTR exon-humanized mice provide a useful model for evaluating genotype-dependent TTR deposition and support the possibility that RBP4 functions as a natural stabilizer of circulating TTR.
- 19 August 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (03) , 01-17
Open AccessTTR Exon-Humanized Mice as a Model for Genotype-Dependent Transthyretin Deposition: Supportive Evidence for RBP4 as a Natural Stabilizer
Transthyretin amyloidosis is caused by destabilization, dissociation, and tissue deposition of transthyretin (TTR). Although several transgenic and knock-in mouse models have been generated, many models are limited by nonphysiological copy number, low expression, or the formation of hybrid tetramers between mouse and human TTR. We previously generated TTR exon-humanized mice in which mouse Ttr exons were replaced with corresponding human TTR exons while preserving the mouse genomic structure. In the present study, we introduced the Val30Met mutation into the TTR exon-humanized allele and generated three genotypes: TtrhTTRV30e/hTTRV30e, TtrhTTRM30e/hTTRM30e, and TtrhTTRV30e/hTTRM30e mice. We examined non-fibrillar human TTR deposition by immunohistochemistry in ileum, kidney, and sciatic nerve at 26 and 52 weeks of age, using a semi-quantitative scoring system. Genotype-dependent TTR deposition was observed in multiple tissues. TTR deposition was prominent in V30/V30 and V30/M30 mice, whereas M30/M30 mice consistently showed lower deposition scores. Notably, TTR-positive deposits were detected in the sciatic nerve at 52 weeks of age. Direct fast scarlet staining did not detect amyloid fibrils, indicating that the observed deposits represented non-fibrillar or pre-amyloid TTR deposition. Serum human TTR levels showed modest genotype-dependent differences, whereas serum mouse RBP4 levels differed markedly among genotypes. Supportive computer simulation analysis suggested that the predicted binding stability between mouse RBP4 and TTR was highest for mouse TTR, intermediate for human TTR Met30, and lowest for human TTR Val30. These findings indicate that TTR exon-humanized mice provide a useful model for evaluating genotype-dependent TTR deposition and support the possibility that RBP4 functions as a natural stabilizer of circulating TTR.
- Open Access
- 16 June 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (02) , 01-07
Limitations of Generative AI for Numerical Aggregation of Apple Health Step Count Data: A Validation Study Using XML Records, Manual Calculation, and Health Auto Export
Background: Generative artificial intelligence (AI) tools are increasingly used to assist data handling and research workflows. However, their reliability for numerical aggregation of raw health data has not been fully validated. Objective: This study examined whether generative AI could accurately aggregate Apple Health step count data from original XML records and compared the results with manual calculation and Health Auto Export. Methods: Step count records were extracted from Apple Health XML data. The original data consisted of multiple measurement records per day. Daily step counts were calculated using four approaches: two independent aggregations using Apple Intelligence plus ChatGPT, Health Auto Export, and manual calculation in Excel from the original XMLderived records. Daily totals and weekly summaries were compared across methods. Results: The two AI-based aggregations produced different daily and total step counts and did not agree with either Health Auto Export or manual calculation. In contrast, Health Auto Export and manual Excel calculation showed complete agreement for all daily step counts examined. The initial AI-based analysis also incorrectly treated the data as steps per measurement rather than steps per day. Conclusion: Generative AI was unreliable for primary numerical aggregation of Apple Health step count data, even for simple summation tasks. Health Auto Export, validated against manual calculation, provided reproducible daily step count data suitable for subsequent analysis. Generative AI may be useful for research planning, interpretation, and manuscript preparation, but raw data extraction, numerical aggregation, and statistical calculation should be performed using reproducible computational tools.
- 16 June 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (02) , 01-07
Open AccessLimitations of Generative AI for Numerical Aggregation of Apple Health Step Count Data: A Validation Study Using XML Records, Manual Calculation, and Health Auto Export
Background: Generative artificial intelligence (AI) tools are increasingly used to assist data handling and research workflows. However, their reliability for numerical aggregation of raw health data has not been fully validated. Objective: This study examined whether generative AI could accurately aggregate Apple Health step count data from original XML records and compared the results with manual calculation and Health Auto Export. Methods: Step count records were extracted from Apple Health XML data. The original data consisted of multiple measurement records per day. Daily step counts were calculated using four approaches: two independent aggregations using Apple Intelligence plus ChatGPT, Health Auto Export, and manual calculation in Excel from the original XMLderived records. Daily totals and weekly summaries were compared across methods. Results: The two AI-based aggregations produced different daily and total step counts and did not agree with either Health Auto Export or manual calculation. In contrast, Health Auto Export and manual Excel calculation showed complete agreement for all daily step counts examined. The initial AI-based analysis also incorrectly treated the data as steps per measurement rather than steps per day. Conclusion: Generative AI was unreliable for primary numerical aggregation of Apple Health step count data, even for simple summation tasks. Health Auto Export, validated against manual calculation, provided reproducible daily step count data suitable for subsequent analysis. Generative AI may be useful for research planning, interpretation, and manuscript preparation, but raw data extraction, numerical aggregation, and statistical calculation should be performed using reproducible computational tools.
- 30 April 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (02) , 01-05
Objective Identification of Pharmacological Interference in Parkinsonian Gait Using Continuous Digital Phenotyping
Building upon our previous demonstration that Apple HealthKit enables longitudinal monitoring of Parkinsonian gait [1], this study evaluates its utility for short-term pharmacological assessment. Using a self-controlled longitudinal design, gait performance was quantified across four pharmacological phases: pre-medication, on-medication, withdrawal day, and post-withdrawal recovery. Objective gait parameters—including coefficient of variation (CV), walking speed, asymmetry, and step length—were derived from real-world walking data. Rotigotine administration resulted in marked deterioration in gait stability, characterized by a substantial increase in CV and worsening asymmetry, accompanied by reduced step length. These abnormalities were further exacerbated on the withdrawal day and were rapidly reversible following discontinuation, with CV decreasing to below baseline levels. These findings demonstrate that continuous digital phenotyping enables objective identification of pharmacological interference and supports data-driven, individualized treatment strategies in Parkinson’s disease.
- 30 April 2026
- Published by Opast Group LLC in Advances in Neurology and Neuroscience
- Vol. 09 (02) , 01-05
Objective Identification of Pharmacological Interference in Parkinsonian Gait Using Continuous Digital Phenotyping
Building upon our previous demonstration that Apple HealthKit enables longitudinal monitoring of Parkinsonian gait [1], this study evaluates its utility for short-term pharmacological assessment. Using a self-controlled longitudinal design, gait performance was quantified across four pharmacological phases: pre-medication, on-medication, withdrawal day, and post-withdrawal recovery. Objective gait parameters—including coefficient of variation (CV), walking speed, asymmetry, and step length—were derived from real-world walking data. Rotigotine administration resulted in marked deterioration in gait stability, characterized by a substantial increase in CV and worsening asymmetry, accompanied by reduced step length. These abnormalities were further exacerbated on the withdrawal day and were rapidly reversible following discontinuation, with CV decreasing to below baseline levels. These findings demonstrate that continuous digital phenotyping enables objective identification of pharmacological interference and supports data-driven, individualized treatment strategies in Parkinson’s disease.